Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers
Status:
Withdrawn
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability of the use of telaprevir in the setting of
post-exposure prophylaxis among HCW exposed to HCV genotype 1 or genotype 2.
To assess the election rate of postexposure prophylaxis for HCV-related occupational
exposures in HCW.